Complete FDA and NHTSA recall records dated in February 2024.
These records include useful source details for the selected month.
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual…
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male…
Failed Impurities/Degradation Specification: Out of specification for organic impurities
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.
CGMP Deviations: potential presence of Burkholderia cepacia complex
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Chemical Contamination; presence of benzene.
Labeling: Incorrect or Missing Package Insert
Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified…
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male…
CGMP Deviations: Potential Glass and Silicone particulates in product
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
Toyota Motor Engineering & Manufacturer (Toyota) is recalling certain 2022-2023 Tacoma vehicles. The axle shaft sub-assembly may separate from the axle housing due to debris causing…
Nissan North America, Inc. (Nissan) is recalling certain 2024 Titan, Frontier, Infiniti QX60, Pathfinder, 2023-2024 Sentra, Versa, Kicks, Infiniti QX50, and 2023 Rogue vehicles. Due to a…
Tesla, Inc. (Tesla) is recalling certain 2013, 2018-2021 Model S, 2020-2021 Model X, 2018-2022 Model 3, and 2020-2022 Model Y vehicles. A factory reset muted the Pedestrian Warning System…
Kia America, Inc. (Kia) is recalling certain 2020 Telluride vehicles. The high beam headlights may fail.
Ford Motor Company (Ford) is recalling certain 2022-2023 Maverick Hybrid vehicles. The Instrument Panel Cluster may not properly illuminate warning lights or gauges. As such, these vehicles…
Ford Motor Company (Ford) is recalling certain 2023-2024 Bronco and Bronco Heritage vehicles. The rear quarter glass panels may have been improperly installed to the vehicle hard top, which…
General Motors, LLC (GM) is recalling certain 2023 Chevrolet Colorado and GMC Canyon vehicles. The front camera module (FCM) system may falsely detect an obstacle, causing the automatic…
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Ram Promaster vehicles. The driver seat belt warning light and audible chime may not activate as intended. As such, these vehicles fail…
Chrysler (FCA US, LLC) is recalling certain 2023-2024 Jeep Grand Cherokee and Jeep Grand Cherokee L vehicles. When the master headlight switch is set to the AUTO position, the driver may be…
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
